Radient Technologies Inc. receives Controlled Drugs and Substances Licence for its Manufacturing Facility

Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is pleased to announce that it has received its Controlled Drugs and Substances Licence, also known as a Dealer’s Licence (the “Licence”), from Health Canada’s Office of Controlled Substances for its Manufacturing Facility located at 4035 – 101 NW Street, Edmonton, Alberta.  

Canopy Rivers Announces Proposed Restructuring of Investment in TerrAscend

Canopy Rivers Inc. (TSXV: RIV) is pleased to announce it has entered into an arrangement agreement  through its wholly-owned subsidiary, Canopy Rivers Corporation , with TerrAscend Corp. (CSE: TER) pursuant to which TerrAscend will restructure its share capital by way of a plan of arrangement under the Business Corporations Act (Ontario).

The Future Is Bright For This U.S. Cannabis Leader In The Making

The Florida medical cannabis market represents a significant opportunity as the number of registered patients continues to record strong growth. Since March 2018, the patient count has more than doubled to around 170,000 state wide in a state with over 20 million residents. We expect to see the number of medical cannabis patients continue to increase as the number of indications approved by the state increases.

3 Canadian Cannabis Stocks To Watch Going Into The Weekend

The cannabis sector has become a major topic discussion with mainstream financial media outlets and this is a trend that we are watching.

The interest was driven by some high-flying stocks and we are monitoring how the sector closes out the week. Today, we wanted to highlight 3 companies that have been highlighted on CNBC and provide an update on these leading Canadian opportunities.

Tilray: Watching the Decline

Pages